- Home
- CRIS vs SXTC Comparison
CRIS vs SXTC Comparison
Compare CRIS & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- SXTC
- Stock Information
- Founded
- CRIS 2000
- SXTC 2005
- Country
- CRIS United States
- SXTC China
- Employees
- CRIS N/A
- SXTC N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- CRIS Health Care
- SXTC Health Care
- Exchange
- CRIS Nasdaq
- SXTC Nasdaq
- Market Cap
- CRIS 13.5M
- SXTC 14.0M
- IPO Year
- CRIS 2000
- SXTC 2019
- Fundamental
- Price
- CRIS $1.96
- SXTC $1.65
- Analyst Decision
- CRIS Strong Buy
- SXTC
- Analyst Count
- CRIS 3
- SXTC 0
- Target Price
- CRIS $21.00
- SXTC N/A
- AVG Volume (30 Days)
- CRIS 106.4K
- SXTC 12.1M
- Earning Date
- CRIS 05-06-2025
- SXTC 01-01-0001
- Dividend Yield
- CRIS N/A
- SXTC N/A
- EPS Growth
- CRIS N/A
- SXTC N/A
- EPS
- CRIS N/A
- SXTC 20.77
- Revenue
- CRIS $11,202,000.00
- SXTC $1,818,404.00
- Revenue This Year
- CRIS $2.62
- SXTC N/A
- Revenue Next Year
- CRIS $9.84
- SXTC N/A
- P/E Ratio
- CRIS N/A
- SXTC $0.10
- Revenue Growth
- CRIS 14.17
- SXTC 6.78
- 52 Week Low
- CRIS $1.02
- SXTC $0.30
- 52 Week High
- CRIS $16.93
- SXTC $5.70
- Technical
- Relative Strength Index (RSI)
- CRIS 52.24
- SXTC 44.76
- Support Level
- CRIS $1.06
- SXTC $1.45
- Resistance Level
- CRIS $2.45
- SXTC $2.21
- Average True Range (ATR)
- CRIS 0.30
- SXTC 0.43
- MACD
- CRIS 0.02
- SXTC -0.01
- Stochastic Oscillator
- CRIS 36.19
- SXTC 40.71
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.